Summary
Modulation of tumour cell growth by tumour-infiltrating leucocytes is of high importance for the biological behaviour of malignant neoplasms. In melanoma, tumour-associated macrophages (TAM) and tumour-infiltrating lymphocytes (TIL) are of particular interest as inhibitors or enhancers of cell growth. Recruitment of leucocytes from the peripheral blood into the tumour site is mediated predominantly by chemotaxins, particularly by the group of chemokines.
The aim of this study was to identify peptides released by human melanoma cells with monocyte chemotactic properties. To assure the presence of biologically active mediators, biochemical purification and biological characterization of peptides was based on a detection system dependent on bioactive, monocyte chemotactic activity in vitro. Cell culture supernatants of melanoma cells were fractioned by heparin–sepharose followed by preparative reversed-phase HPLC steps to enrich monocyte chemotactic activity in one single band on a sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) gel. These purified fractions were shown to react with RANTES-specific antibodies in an enzyme-linked immunosorbent assay (ELISA) as well as in Western blot analysis. Amino acid sequencing of the N-terminal protein fragment confirmed 100% homology to the RANTES protein. Further analysis showed that four out of eight melanoma cell lines constitutively expressed and secreted the β-chemokine RANTES as detected by ELISA. The amount of RANTES protein secreted (up to 50 ng ml–1) was about 5–50 times higher than interleukin 8 (IL-8), determined in the same supernatant samples. Tumour necrosis factor α (TNF-α), not, however, IL-2, interferon-γ (IFN-γ), or α-melanocyte-stimulating hormone (α-MSH) was able to up-regulate RANTES and interleukin 8 secretion. Furthermore, higher levels of RANTES secretion in vitro were associated with increased tumour formation upon S.C. injection of six human melanoma cell lines in nude mice. Our data provide evidence that a subset of melanoma cells express mRNA and secrete RANTES protein which may be partly responsible for the recruitment of monocytes, T-cells and dendritic cells into the tumours. However, transplantation experiments in nude mice suggest that effects of RANTES may also benefit tumour progression. Further studies are needed to dissect the underlying mechanisms.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Artuc, M., Nürnberg, W., Czarnetzki, B. M. & Schadendorf, D. (1995). Characterization of gene regulatory elements for selective gene expression in human melanoma cells. Biochem Biophys Res Commun 213: 699–705.
Balaban, G., Herlyn, M., Guerry, D. 4., Bartolo, R., et al (1984). Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Genet Cytogenet 11: 429–439.
Barnhill, R. L. (1993). Pathology and prognostic factors. Curr Opin Oncol 5: 364–376.
Benomar, A., Ming, W. J., Taraboletti, G., Ghezzi, P., et al (1987). Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude mice. J Immunol 138: 2372–2379.
Bottazzi, B., Polentarutti, N., Acero, R., Balsari, A., et al (1983). Regulation of the macrophage content of neoplasms by chemoattractants. Science 220: 210–212.
Bröcker, E. B., Zwadlo, G., Holzmann, B., Macher, E., et al (1988). Inflammatory cell infiltrates in human melanoma at different stages of tumor progression. Int J Cancer 41: 562–567.
Cornil, I., Theodorescu, D., Man, S., Herlyn, M., et al (1991). Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci USA 88: 6028–6032.
Degli-Esposti, M. A., Davis-Smith, T., Din, W. S., Smolak, P. J., et al (1997). Activation of the lymphotoxin β receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells. J Immunol 158: 1756–1762.
Engler-Blum, G., Meier, M., Frank, J. & Müller, H. (1993). Reduction of background problems in nonradioactive northern and southern blot analyses enables higher sensitivity than 32P-based hybridizations. Anal Biochem 210: 235–239.
Ferrone, S. (1994). Melanoma, immune surveillance, and immunotherapy. J Clin Invest 93: 1351–1352.
Gläser, R., Rass, K., Seiter, S., Hauschild, A., et al (1997). Detection of circulating melanoma cells by specific amplification of tyrosinase complentary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study. J Clin Oncol 15: 2818–2825.
Graves, D. T., Barnhill, R., Galanopoulos, T. & Antoniades, H. N. (1992). Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am J Pathol 140: 9–14.
Herlyn, M., Balaban, G., Bennicelli, J., Guerry, D. 4., et al (1985a). Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. J Natl Cancer Inst 74: 283–289.
Herlyn, M., Thurin, J., Balaban, G., Bennicelli, J. L. et al (1985a). Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res 45: 5670–5676.
Ibrahim, M. A., Chain, B. M. & Katz, D. R. (1995). The injured cell: the role of the dendritic cell system as a sentinel receptor pathway. Immunol Today 16: 181–186.
Mattei, S., Colombo, M. P., Melani, C., Silvani, A., et al (1994). Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 56: 853–857.
Mrowietz, U. & Jürgens, G. (1995). A method for the determination of leukocyte migration for large sample numbers by automated densitometric quantification. J Biochem Biophys Methods 30: 49–58.
Rigel, D. S., Friedman, R. J. & Kopf, A. W. (1996). The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 34: 839–847.
Rivers, J. K. (1996). Melanoma. Lancet 347: 803–806.
Schadendorf, D., Möller, A., Algermissen, B., Worm, M., et al (1993). IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 151: 2667–2675.
Schadendorf, D., Fichtner, I., Makki, A., Alijagic, S., et al (1996). Metastatic potential of human melanoma cells in nude mice – characterization of phenotype, cytokine secretion and tumour-associated antigens. Br J Cancer 74: 194–199.
Schall, T. J., Jongstra, J., Dyer, B. J., Jorgensen, J., et al (1988). A human T cell-specific molecule is a member of a new gene family. J Immunol 141: 1018–1025.
Schall, T. J., Bacon, K., Toy, K. J. & Goeddel, D. V. (1990). Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347: 669–671.
Schall, T. J. & Bacon, K. B. (1994). Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 6: 865–873.
Singh, R. K. & Varney, M. L. (1998). Regulation of interleukin 8 expression in human malignant melanoma cells. Cancer Res 58: 1532–1537.
Sozzani, S., Sallusto, F., Luini, W., Zhou, D., et al (1995). Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J Immunol 155: 3292–3295.
Sticherling, M., Schröder, J. M. & Christophers, E. (1989). Production and characterization of monoclonal antibodies against the novel neutrophil activating peptide NAP/IL-8. J Immunol 143: 1628–1634.
Sticherling, M., Küpper, M., Koltrowitz, F., Bornscheuer, E., et al (1995). Detection of the chemokine RANTES in cytokine-stimulated human dermal fibroblasts. J Invest Dermatol 105: 585–591.
Te Velde, A. A. & Figdor, C. G. (1991). Monocyte-mediated cytotoxic activity against melanoma. Melanoma Res 1: 303–309.
Uguccioni, M., D’Apuzzo, M., Loetscher, M., Dewald, B., et al (1995). Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1α and MIP-1β on human monocytes. Eur J Immunol 25: 64–68.
Van Ravenswaay-Claasen, H. H., Kluin, P. M. & Fleuren, G. J. (1992). Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity. Lab Invest 67: 166–174.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Mrowietz, U., Schwenk, U., Maune, S. et al. The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. Br J Cancer 79, 1025–1031 (1999). https://doi.org/10.1038/sj.bjc.6690164
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690164
Keywords
This article is cited by
-
CCL5-deficiency enhances intratumoral infiltration of CD8+ T cells in colorectal cancer
Cell Death & Disease (2018)
-
Collagen IV-conveyed signals can regulate chemokine production and promote liver metastasis
Oncogene (2018)
-
Human MSCs promotes colorectal cancer epithelial–mesenchymal transition and progression via CCL5/β-catenin/Slug pathway
Cell Death & Disease (2017)
-
Systemic Administration of Platelets Incorporating Inactivated Sendai Virus Eradicates Melanoma in Mice
Molecular Therapy (2014)
-
Differential association of RANTES-403 and IL-1B-1464 polymorphisms on histological subtypes in male Korean patients with gastric cancer
Tumor Biology (2014)